|
 |
|
WINTER 2008 |
||||||||||||||||||||||||||||
PerspectivesLetters Cancer Controversy in Cardiology: Does Ezetimibe Raise Cancer Risk? Genomic Medicine: Breaking the Code
Brain TumorsTemozolomide Fails to Best PCV in High-Grade Gliomas Whole Brain Irradiation Risks Cognitive Problems
Breast CancerMolecular Breast Imaging Sees Tumors in Dense Breasts MBI Needs Dose Reduction to Be Alternative to Mammography New Cardiac Guidelines for Trastuzumab Troponin, BNP Testing Advocated for Detecting Cardiotoxicity Trastuzumab-Tied Heart Damage More Common in Clinic Accelerated Whole-Breast Irradiation as Good as Standard Dose HER2 Conversion During Treatment May Explain Trastuzumab Resistance Insurer to Pay for Extra HER2 Tests Adjuvant Chemo Overcomes Poor BRCA1 and BRCA2 Prognoses
Gastrointestinal MalignanciesVioxx Fails to Aid Survival, But Some Patients Benefit DNA-Based Colon Cancer Screen Has 80% Sensitivity Endoscopic Injection of Biologic Tames Esophageal Tumors Heat Shock Protein 90 Inhibitor: 1st Phase III Trial Targets GIST EndoTAG-1 Plus Gemcitabine Ups Survival in Pancreatic Cancer Preoperative Staging by CT Favored in Pancreatic Cancer
Genitourinary MalignanciesAdding Radiotherapy to Hormones Boosts Survival Web Tool Focuses Prostate Cancer Treatment Decisions Mortality Higher in Older Men With NHT, Brachytherapy 8-Month NHT Improves Freedom From Failure, but Not Survival Provenge Vaccine Fails to Meet Interim Study End Point Sorafenib Benefit Shown in Elderly Patients With Advanced RCC
Gynecologic MalignanciesTrabectedin Delays Progression of Recurrent Ovarian Cancer Intense Radiotherapy Fails to Aid Survival in Cervical Cancer Sexual Dysfunction After Gyn. Cancer Care 1 in 10 Survivors Reports 'Unexpected Defecation' Commentary: Life After Treatment of Gynecologic Malignancies
Head and Neck CancersPhase II Study Finds Chemoradiation Plus Cetuximab Safe EXTREME: Cetuximab Plus Chemo Raises Progression-Free Survival Cetuximab + Radiation Survival Gain Is Durable at 5 Years Weekend Breaks Don't Cut Efficacy of Accelerated Radiotherapy Standard Chemoradiation Tops Accelerated Regimen Low -Tubulin II: Longer Survival in Advanced HNSCC P16 Positivity Means Better Oropharyngeal Cancer Survival FAQs on HPV in Head and Neck Cancers Answered Viral DNA Level Predicts Nasopharyngeal Carcinoma Outcome New Drug Class Making Waves in Advanced Thyroid Cancer Should Endocrinologists Prescribe Tyrosine Kinase Inhibitors? Novel Strategy Reduces Radioiodine Use in Thyroid Cancer Amifostine Does Not Affect Survival in Head and Neck Cancer
|
Hematologic MalignanciesBiologic Prognostic CLL Markers Have Limited Use So Far Rare Case of Relapsing Leukemia Cutis Appears Only in Skin Nonablative Allogeneic Transplants Tame Some Lymphomas New & Approved: Ontak Solution for IV Injection Subcutaneous Panniculitic T-Cell Lymphoma Has Two Types Exceptions Seen in Histology of Rare Aggressive Lymphoma New & Approved: Treanda for Injection Outpatient Transplant in Multiple Myeloma: Two Views Gene Variants Can Predict Mortality in Multiple Myeloma Don't Rely Only on Scoring Systems When Deciding Care for Myelodysplasia Common Errors in Treatment of Myelodysplasia Trials of JAK2 Inhibitors Offer Hope for Myeloproliferative Disorders JAK2 Testing Influences Prognosis of Myeloproliferative Disorders
Lung CancerAVAIL: Bevacizumab Fails in Final Survival Analysis EGFR Screening Extends Survival With Erlotinib Use First-Line Gefitinib Benefits Asian Patients With NSCLC PCR Test Can Tell Squamous From Nonsquamous NSCLC New & Approved: Alimta
MelanomaTemozolomide Fails to Improve Survival in EORTC Trial After EORTC 18032: Is Melanoma Research at an Impasse? Delayed Response Seen With New Anti-CTLA-4 Agents Melanoma Risk Increases With TNF Blockers in Cancer Survivors False-Negative Sentinel Biopsy Rate Higher in Head, Neck Thin Melanoma Regression Insufficient to Order SLN Biopsy
Patient CareCancer Outcomes Improved With Palliative Care Nursing Single Dose of Radiotherapy Eases Spinal Compression Intravenous Iron Boosts Erythropoiesis During Chemotherapy Joint Stiffness Is Common With Aromatase Inhibitor Therapy New & Approved: Sancuso Transdermal System Palifermin Reduces Oral Mucositis but Skeptics Question Safety
Practice TrendsPhysician Fee Rule Includes 1.1% Raise, Plus Bonuses ICD-10 Transition Likely to Carry Big Price Tag for Physicians Medicare Offers Bonus to Push E-Prescribing Beginning in 2009 E-Prescribing: Qualifying for the Medicare Bonus Black Box Warning on ESAs May Justify Higher Billings Add Revenue Sources to Cope, Community Oncologists Urged Managing Cash Flow in a Community Oncology Group
Copyright © 2008 by Elsevier Inc. All rights reserved. No part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopy, recording, or any information storage and retrieval system, without written permission from the publisher. | |||||||||||||||||||||||||||
55 kb